Antihistamines for atopic dermatitis.
Phillips
R L
RL
University of Missouri-Columbia, USA. phillipsrl@health.missouri.edu
Koenig
C J
CJ
D000293:Adolescent; D000328:Adult; D000368:Aged; D000982:Antipruritics / Q000627:therapeutic use*; D017332:Cetirizine / Q000627:therapeutic use; D002648:Child; D002974:Clemastine / Q000627:therapeutic use; D003876:Dermatitis, Atopic / Q000150:complications* / Q000188:drug therapy*; D004311:Double-Blind Method; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D011537:Pruritus / Q000188:drug therapy* / Q000209:etiology*; D016032:Randomized Controlled Trials as Topic; D011956:Receptors, Cell Surface / Q000008:administration & dosage*; D055293:Receptors, Urokinase Plasminogen Activator; D015203:Reproducibility of Results; D016593:Terfenadine / Q000627:therapeutic use; D016896:Treatment Outcome
D000982:Antipruritics; D006634:Histamine H1 Antagonists; C524898:PLAUR protein, human; D011956:Receptors, Cell Surface; D055293:Receptors, Urokinase Plasminogen Activator; D016593:Terfenadine; D002974:Clemastine; D017332:Cetirizine